Vironova AB (publ) is a privately held Swedish biotech company dedicated to the development of novel antiviral therapeutics and virus diagnostics products to combat and prevent the spread of viral diseases. Based on proprietary technology to analyze viruses in digital images acquired by transmission electron microscopy (TEM), Vironova also provides services for the pharmaceutical industry that is able to cut time and costs in viral related R&D and production of biologicals.

VIRONOVA NYEMISSION, JULI 2009 / VIRONOVA SHARE ISSUE, JULY 2009

Mer information om nyemissionen återfinns i nyhet publicerad 23:e juni, 2009
Ladda ner: Information Memorandum; Villkor och anvisningar; Anmälningssedel för teckning av aktier utan stöd av teckningsrätter
---
More information on the share issue can be found in the news posted on June 23, 2009
Download: Information Memorandum; Terms and instructions; Subscription Form for subscription without subscription rights

Company presentation